2022 annual financial data
Candel Therapeutics 2022 Operating margin
Direct answer
Operating margin was -27,739.2%.
Operating income was -34,674,000 USD and net income was -18,794,000 USD.
Operating cash flow was Not available.
Get free Candel Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 125,000 USD
- Operating income
- -34,674,000 USD
- Net income
- -18,794,000 USD
- Operating cash flow
- Not available